JAMA paper says COVID-19 antiviral does little for vaccinated over-70s, but experts point to study limitations
Professors Allen Cheng and Paul Griffin cautioned against extrapolating the findings to Australia.
COVID-19 antiviral nirmatrelvir-ritonavir cuts neither hospitalisations nor deaths among vaccinated older adults, a US-Canadian study has suggested.
However, Australian experts say the ‘natural experiment’ study is hard to extrapolate.
